title: Eslicarbazepine acetate in the management of refractory bipolar disorder.
abstract: Eslicarbazepine acetate is a novel third-generation antiepileptic related to carbamazepine and oxcarbazepine with a benign adverse effect profile. We report a patient with bipolar mania with intolerance to multiple antimanic drugs, responding to eslicarbazepine without any serious adverse effect.
authors.affiliation: Department of Psychiatry, Silchar Medical College and Hospital, Silchar, Assam, India.
authors.forename: Kamal
authors.initials: K
authors.lastname: Nath
authors.forename: Arnab
authors.initials: A
authors.lastname: Bhattacharya
authors.forename: Samir Kumar
authors.initials: SK
authors.lastname: Praharaj
mesh_terms: D000927:Anticonvulsants / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000175:diagnosis* / Q000188:drug therapy* / Q000523:psychology; D003984:Dibenzazepines / Q000627:therapeutic use*; D019468:Disease Management; D006801:Humans; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D000927:Anticonvulsants; D003984:Dibenzazepines; C416835:eslicarbazepine acetate